- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06708234
Frequency of Isthmocele Following Single- Vs Double-layer Uterine Closure.
November 24, 2024 updated by: Lorenza Driul
Frequency of Isthmocele Following Single- Vs Double-layer Uterine Closure. a Prospective and Retrospective Multicenter Observational Study
The main objective of this study is to compare the frequency of isthmocele after caesarean section according to the type of hysteroraffia performed (single or double layer suture).
Study Overview
Status
Recruiting
Conditions
Detailed Description
The effects of caesarean sections on maternal health have long been known and are an issue of great interest and concern every time these epidemiological data are analysed.
Among the late complications reported in the literature, several publications have analysed the correlation between the presence of abnormal uterine bleeding in the postmenstrual phase and the presence of a defect in the anterior wall of the uterine isthmus at the site of a previous caesarean section scar.
Although this clinical picture, termed isthmocele, has been known for some time, its aetiopathogenesis and implications have so far been rather underestimated.
The isthmocele is a saccated diverticulum of the anterior wall of the uterus in continuity with the uterine cavity, which forms at the level of the isthmus, at the site of a previous hysterectomy by caesarean section.
This wall defect can lead to symptoms such as menorrhagia, abnormal uterine bleeding, pelvic pain and dysmenorrhoea.
pelvic pain and dysmenorrhoea, and can also cause 'scar pregnancy' and secondary infertility.
This complication occurs in more than 50% of women who undergo a caesarean section, and this percentage increases in relation to the number of previous caesarean sections.
Currently, treatment options include conservative treatment, based on combined oestrogen-progestin therapy, and surgical treatment, based on hysteroscopic, laparoscopic or transvaginal repair.
The choice is made on the basis of the extent of the defect, presence of symptoms, concomitant secondary infertility and desire for offspring.
Although the possibility of treating isthmocele exists, in recent years interest has shifted to the possibility of preventing the occurrence of this complication.
Among the risk factors recognised to date are include uterine position in retroversion and multiple caesarean sections.
However, they may also contribute.
However, factors such as a low uterine incision, incomplete closure of the hysterotomy, the appearance of early uterine wall adhesions and a genetic predisposition of the patient can also contribute to the development of a isthmus.
A study of the risk factors associated with the occurrence of this problem showed that the technique of suturing is the most modifiable risk factor.
In this regard, some studies have suggested that a double-layer closure of the uterine breach reduces the occurrence of isthmocele and increases the residual myometrial thickness, but systematic reviews of the literature have found no difference between patients undergoing single- and double-layer hysteroraffia, while they have shown that hollow sutures may lead to a larger isthmocele and a higher risk of uterine rupture, without providing any substantial haemostatic benefit.
substantial haemostatic benefits.
To date, there are no guidelines identifying the optimal time to perform evaluation of the cesarean section scar and diagnose the possible presence of a isthmocele.
The isthmocele presents itself sonographically as a triangular anechogenic space, at least 2 mm deep, in the context of the anterior uterine wall, at the presumed site of the caesarean section scar with the base communicating with the uterine cavity.
It should not be confused with the caesarean section scar itself, which appears as a hypercogenic line at the presumed site or with similar echogenicity to the surrounding myometrium.
Most authors have focused on measuring the depth of the isthmocele, the size of the residual myometrial thickness and only a few have distinguished the extent of the defect into major or minor on the basis of the percentage of myometrium involved.
However, other highly relevant parameters such as defect shape, volume, location, presence of multiple anechogenic areas etc. were not taken into account.
The accurate measurement and description of these lesions is becoming increasingly important, for research, for the clinical assessment of gynaecological symptoms and for the planning of possible surgical treatment.
For this reason, in 2019 Jordans et al. published an expert consensus 'Delphi protocol' to describe a standardised methodology for ultrasound assessment of isthmocele in patients non-pregnant women.
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lorenza Driul
- Phone Number: +00393358385138
- Email: lorenza.driul@uniud.it
Study Contact Backup
- Name: Silvia Zermano
- Phone Number: +00393468624022
- Email: silvia.zermanso@asufc.sanita.fvg.it
Study Locations
-
-
-
Udine, Italy, 33100
- Recruiting
- Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Clinica Ostetrica e Ginecologica Udine
-
Contact:
- Lorenza Driul
-
Contact:
- Lorenza Driul
- Phone Number: +00393358385138
- Email: lorenza.driul@uniud.it
-
Contact:
- Silvia Zermano
- Phone Number: +00393468624022
- Email: silvia.zermano@asufc.sanita.fvg.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
patients attending the Friuli Centrale University Health Authority - Obstetrics and Gynaecology of Tolmezzo
Description
Inclusion Criteria:
- Patients undergoing elective or emergency/emergency caesarean section at the centres involved.
Exclusion Criteria:
- Age <18 years;
- Pregnant women at the time of ultrasound assessment;
- Refusal to perform transvaginal ultrasound;
- Type of hysterorrhaphy performed during surgery not known;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
single layer
patients who underwent caesarean section with hysteroraffia performed in single layer
|
|
double layer
patients who underwent caesarean section with double-layer hysteroraffia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of isthmocele
Time Frame: 3-4 months post cesarean section
|
The main objective of this study is to compare the frequency of isthmocele after caesarean section according to the type of hysteroraffia performed (single or double layer suture).
|
3-4 months post cesarean section
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Different features of isthmocele according to type of hysteroraffia
Time Frame: 3-4 months post cesarean section
|
To determine whether there are differences in isthmocele volume and residual myometrial thickness between patients undergoing hysteroraffia by single or double layer.
|
3-4 months post cesarean section
|
|
The role of anamnestic data of patients as risk factor for isthmocele
Time Frame: at enrollment
|
Assess the impact of anamnestic data as possible risk factors for the development of isthmocele in the population considered.
|
at enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 9, 2024
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
November 1, 2025
Study Registration Dates
First Submitted
November 24, 2024
First Submitted That Met QC Criteria
November 24, 2024
First Posted (Estimated)
November 27, 2024
Study Record Updates
Last Update Posted (Estimated)
November 27, 2024
Last Update Submitted That Met QC Criteria
November 24, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 154230
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Isthmocele
-
University Hospital, Basel, SwitzerlandCompleted
-
Minia UniversityNot yet recruiting
-
Kanuni Sultan Suleyman Training and Research HospitalEnrolling by invitation
-
Tokat Gaziosmanpasa UniversityCompletedCesarean Section Complications | IsthmoceleTurkey
-
Ospedale Policlinico San MartinoCompletedCesarean Section Complications | Uterine Niche | Isthmocele | Uterine Scar DefectsItaly
-
Kantonsspital BadenNot yet recruitingCesarean Scar Diverticula | IsthmoceleSwitzerland
-
Gaziosmanpasa Research and Education HospitalCompletedPelvic Pain | Isthmocele | Post-menstrual Spotting BleedingTurkey
-
Hospital Clinic of BarcelonaRecruitingInfertility | Pelvic Pain | Uterine Niche | Isthmocele | Spotting | Cesarean Scar Defect | Niche | Uterine Abnormal BleedingSpain